Allogene Therapeutics Inc (NAS:ALLO)
$ 2.99 -0.01 (-0.33%) Market Cap: 625.25 Mil Enterprise Value: 269.70 Mil PE Ratio: 0 PB Ratio: 1.22 GF Score: 34/100

Allogene Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2021 / 02:00PM GMT
Release Date Price: $25.76 (+3.58%)
David D. Chang
Allogene Therapeutics, Inc. - Co-Founder, President, CEO & Director

Good morning. This is David Chang. I'm the Chief Executive Officer and the Director of Allogene Therapeutics. I'm very happy to welcome you to the Allogene 2021 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform.

In order to conduct an orderly meeting, we ask you to follow the rules of conduct, which are available on the meeting materials online. While the meeting is virtual only, stockholders of record will have the opportunity to submit questions or comment through the text box located on your screen. To ask a question online, enter your question in the box below, Ask A Question, and click Submit button. We will answer questions submitted that are germane to the proposals being voted on as and if we have time. Please submit your questions now to make sure that we have -- they are reviewed and addressed.

If you intend to vote and have not already done so, you must submit your vote online now in order for it to be counted. After we describe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot